Europe – New study shows pioneering test for endometrial cancer could significantly reduce diagnosis time

Research published in the Journal of Clinical Oncology found that relatively low-cost PCR tests were able to successfully detect endometrial cancer (EC) using samples taken from the cervix or vagina.

The pioneering tests, developed by researchers at the University of Innsbruck in Austria and University College London, could mean a significant reduction in the time taken to diagnose patients with EC, and a decrease in the need for more invasive diagnostic procedures.

EC incidence has been rising over the past ten years and patient survival is strongly dependent on the stage at diagnosis, with delays in diagnosis and treatment resulting in significant adverse impacts on survival.

The current route of diagnosis for suspected EC is a transvaginal ultrasound (TVUS) followed by hysteroscopy and endometrial biopsy. The study outlines that a simple test to triage women with at least equivalent accuracy to current standards, without the need for specialist referral, is ‘urgently needed’…